Characterization of naïve, memory and effector T cells in progressive multiple sclerosis

J Neuroimmunol. 2017 Sep 15:310:17-25. doi: 10.1016/j.jneuroim.2017.06.001. Epub 2017 Jun 3.

Abstract

We characterized naïve, central memory (CM), effector memory (EM) and terminally differentiated effector memory (TEMRA) CD4+ and CD8+ T cells and their expression of CD49d and CD26 in peripheral blood in patients with multiple sclerosis (MS) and healthy controls. CD26+ CD28+ CD4+ TEMRA T cells were increased in all subtypes of MS, and CD26+ CD28+ CD8+ TEMRA T cells were increased in relapsing-remitting and secondary progressive MS. Conversely, in progressive MS, CD49d+ CM T cells were decreased and natalizumab increased the circulating number of all six subsets but reduced the frequency of most subsets expressing CD49d and CD26.

Keywords: CD26; CD49; Memory; Natalizumab; Progressive MS; T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antigens, CD / metabolism
  • Cross-Sectional Studies
  • Disability Evaluation
  • Female
  • Flow Cytometry
  • Humans
  • Immunologic Factors / therapeutic use
  • Immunologic Memory / drug effects
  • Immunologic Memory / physiology*
  • Lymphocyte Activation / drug effects
  • Male
  • Middle Aged
  • Multiple Sclerosis / drug therapy
  • Multiple Sclerosis / immunology*
  • Multiple Sclerosis / pathology*
  • Natalizumab / therapeutic use
  • Statistics, Nonparametric
  • T-Lymphocyte Subsets / classification
  • T-Lymphocyte Subsets / immunology*

Substances

  • Antigens, CD
  • Immunologic Factors
  • Natalizumab